2023 – State Expert Center of the Ministry of Health of Ukraine

Mefenamic acid, tablets 500 mg, PrJSC “Fitofarm”, Ukraine

04.01.2024 1287

Summary of the risk management plan for a medicinal product based on mefenamic acid in 500 mg tablets, containing an overview of the epidemiology of diseases (acute respiratory viral infections, influenza, pain syndrome, dysmenorrhea, inflammatory diseases of the musculoskeletal system) and the results of clinical studies of the efficacy and analgesic properties of the medicine. generated automatically

Tsyborat-oftan, eye drops, PrJSC “Fitofarm”, Ukraine

04.01.2024 1071

Summary of the risk management plan for eye drops containing zinc sulfate and boric acid used for bacterial conjunctivitis. Contains an overview of the epidemiology of the disease, treatment outcomes, the safety profile and unknown data on use in pregnant women, during breastfeeding and in children under 12 years of age. compiled automatically

Citramon-F, tablets, PRJSC “Fitofarm”, Ukraine

04.01.2024 1273

Summary of the risk management plan for the medicinal product Citramon-F (tablets) manufactured by PrJSC "Fitofarm". The document contains an overview of the epidemiology of the diseases for which the product is used (pain syndrome, migraine, hyperthermia) and a summary of treatment results. generated automatically

Combilive, hard capsules, JSC “Vitaminy”, Ukraine

04.01.2024 1121

The material is part of the summary of product characteristics of the medicinal product Kombilive (hard capsules) manufactured by JSC “Vitamins” and contains an overview of the epidemiology of biliary system diseases and a summary of treatment results. Intended to inform the public about the efficacy of the product in functional disorders of the biliary tract. generated automatically

Ketorolac-Lubnifarm, solution, JSC “Lubnifarm”, Ukraine

04.01.2024 1302

Summary of the risk management plan for the medicinal product ketorolac in the form of solution for injection 30 mg/mL manufactured by JSC “Lubnyfarm”. The document contains an overview of the epidemiology of postoperative pain, the results of comparative studies of the efficacy and safety of ketorolac, and a list of identified risks, including gastrointestinal bleeding, ulcers and perforations. compiled automatically

Aloe extract liquid, liquid extract, JSC “Lubnyfarm”, Ukraine

04.01.2024 1221

Summary of the risk management plan for a medicinal product in the form of a liquid extract for injection, containing an overview of the epidemiology of ophthalmic diseases (myopia, blepharitis, conjunctivitis, keratitis, iritis, etc.). Intended for healthcare and pharmacovigilance professionals. generated automatically

Ascophen L, tablets, JSC “Lubnypharm”, Ukraine

04.01.2024 1088

Summary of the risk management plan for the medicinal product Ascofen L tablets, containing an overview of the epidemiology of headache, toothache, neuralgia and arthralgia. The document is intended for professionals in the sphere of medicinal product circulation. generated automatically

Ascophen-Extra, tablets, JSC “Lubnypharm”, Ukraine

04.01.2024 1085

Summary of the risk management plan for the medicinal product Ascophen-Extra (tablets, JSC "Lubnypharm"), containing an overview of the epidemiology of diseases, in particular headache, migraine, toothache and neuralgia. generated automatically

Gastral Mint suspension, suspension, LLC “Pharmaceutical Company Zdorovia”, Ukraine

04.01.2024 962

Summary of the risk management plan for a medicinal product registered for the symptomatic treatment of gastroesophageal reflux and heartburn, including in pregnant women. The document describes important risks, risk minimization measures, routine pharmacovigilance activities, and missing information. generated automatically

Diosmectite-Zdorovia, powder, LLC “Pharmaceutical Company Zdorovia”, Ukraine

04.01.2024 951

Summary of the risk management plan for the medicinal product Diosmectite-Zdorovia (powder for oral suspension) — a document describing the important risks of the drug, risk minimization measures and missing information. Intended for healthcare professionals and patients. generated automatically